Does Soy Isoflavones help menopausal symptoms? (Grade B evidence)

Explore current source-reported research for this exact question. These records are separate from the synthesis below; they do not update its grade or establish a recommendation.

Grade B for Soy Isoflavones on menopausal symptoms: the balance of recorded evidence favours a benefit, especially in menopausal women, at moderate certainty, at doses 40–80 mg isoflavones/day.

Exact question reviewed

Population: menopausal women
Intervention: Soy Isoflavones · 40–80 mg isoflavones/day
Comparator: not reported
Outcome: menopausal symptoms
Time horizon: not reported

Bottom line. Grade B for Soy Isoflavones on menopausal symptoms: the balance of recorded evidence favours a benefit, especially in menopausal women, at moderate certainty, at doses 40–80 mg isoflavones/day. [1 other]

Direction: benefit
Magnitude: modest reduction in hot-flash frequency/severity; effect builds over weeks
Grade: B
Certainty: moderate
Clinical meaning: small but potentially useful
Who it applies to: menopausal women
Dose / form studied: 40–80 mg isoflavones/day
Safety: not assessed
The one limitation: Claim-specific limitation details are not available in this public record.

Reviewed not reported · Evidence last changed 2026-07-16 · Open evidence record (version 0)

Grade

what does the grade mean?

Certainty

moderate

what does certainty mean?

Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.

Who it works for

Best-studied in menopausal women. Recorded studied dose: 40–80 mg isoflavones/day.

Evidence

Study	Design	Role	Cite
Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis	peer-reviewed	not classified	PMID:27327802

Why this grade

Reasoning trace

The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.

Audit and version

Claim ID: ec_soy_meno
Claim version: not reported
Governance: legacy, not verified
Clinician review: Not yet reviewed by a licensed clinician
Last evidence search: not reported
Last editorial review: not verified

Public receipt · Machine-readable claim · Methodology

Dose & form

Studied intake: 40–80 mg isoflavones/day.

People say · Evidence shows

“soy is the natural fix for menopause”

Evidence: Grade B — modest reduction in hot-flash frequency/severity; effect builds over weeks.

How it stacks up for menopausal symptoms

Soy Isoflavones vs Black Cohosh for menopausal symptoms — Black Cohosh Grade C
All interventions graded for menopausal symptoms →

Grade history

2026-07-16B → BCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid-27327802] details →

Re-review cadence: every 12 months (Grade A/B) · methodology v1.

Frequently asked

How long does Soy Isoflavones take to work for menopausal symptoms?

This record does not report a studied onset time for Soy Isoflavones and menopausal symptoms. Do not assume a typical timeframe.

What dose was used in studies of Soy Isoflavones for menopausal symptoms?

The recorded studied dose for Soy Isoflavones and menopausal symptoms is 40–80 mg isoflavones/day. This is a source detail, not a dose recommendation.

Does Soy Isoflavones work for menopausal symptoms if I'm not deficient?

The recorded studied population is menopausal women. This field alone does not show whether deficiency or baseline status changes the effect.

Soy Isoflavones or the next-best alternative for menopausal symptoms?

See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.

What this is — and is not

Evidence description: modest reduction in hot-flash frequency/severity; effect builds over weeks
Substrate's interpretation: The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
Discuss with a clinician: If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
Individualized medical advice: Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.

Cite this page

Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.

Plain-text citation

Substrate. Does Soy Isoflavones help menopausal symptoms? (Grade B). https://evidencebased.info/interventions/soyiso/menopause. Updated 2026-07-16.

BibTeX

@misc{substrate_tionssoyisomenopause,
  author = {Substrate editorial},
  title  = {Does Soy Isoflavones help menopausal symptoms?},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/soyiso/menopause},
  note   = {Grade B, evidencebased.info}
}

Found something wrong on this page? Report an error →

Current source-reported research

Membership uses admitted intervention and measured-outcome associations for this exact question. Different populations, preparations, comparators and timepoints remain separate. No pooling or update to the synthesis is asserted.